Freeman Chris
Chief Commercial Officer
Freeman Chris has filed 11 SEC Form 4 filings (48 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Aug 11, 2026.
On the most recent filing, Freeman Chris is listed as Chief Commercial Officer at Guardant Health, Inc. Inside the rolling window, Freeman Chris reported no open-market purchases and 3 open-market sales totaling $16.9M in GH. The largest disclosed transaction in the window is a sale of 63,605 GH shares on Aug 10, 2026, worth $10.8M.
Companies traded
Other insiders at GH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Freeman Chris made?
Freeman Chris has filed 11 SEC Form 4 filings (48 transaction rows) across 1 company since 2025.
Which companies does Freeman Chris trade?
Freeman Chris has filed SEC Form 4 disclosures for 1 company, including GH.
When was Freeman Chris's most recent SEC Form 4 filing?
Freeman Chris's most recent SEC Form 4 filing on Tracefour is dated Aug 11, 2026.
What is Freeman Chris's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Freeman Chris is listed as Chief Commercial Officer.
What is Freeman Chris's total buy and sell value in the current window?
Inside the rolling retention window, Freeman Chris bought $0 and sold $16.9M based on SEC Form 4 filings.
What was Freeman Chris's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 63,605 GH shares on 2026-08-10, worth $10.8M, per SEC Form 4 filings.